| Identification | Back Directory | [Name]
2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy-3’-fluoroguanosine | [CAS]
2389988-77-4 | [Synonyms]
2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy-3’-fluoroguanosine
2',5'-Di-O-acetyl-8-benzyloxy-3'-deoxy-3'-fluoroguanosine
2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy-3’-fluoroguanosine
2',3'-Di-O-acetyl-8-benzyloxy-3'-deoxy-3'-fluoroguanosineconfidential | [Molecular Formula]
C21H22FN5O7 | [MOL File]
2389988-77-4.mol | [Molecular Weight]
475.43 |
| Hazard Information | Back Directory | [Uses]
2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy-3’-fluoroguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|